Taysha Gene Therapies, Inc.

Q4 2022 13F Holders

Symbol
TSHA
CUSIP
877619106
Type
Equity
Class
COM SHS
Num filings
57
Total reported value, excl. options
$44.0 M
Manager Report Date Value ($000) Shares Option Type